These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24768068)

  • 1. [Should we consider newborn screening for Pompe disease?].
    Lacombe D; Verloes A
    Arch Pediatr; 2014 Jun; 21(6):561-3. PubMed ID: 24768068
    [No Abstract]   [Full Text] [Related]  

  • 2. Newborn screening for Pompe disease: an update, 2011.
    Burton BK
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening.
    Chien YH; Lee NC; Huang HJ; Thurberg BL; Tsai FJ; Hwu WL
    J Pediatr; 2011 Jun; 158(6):1023-1027.e1. PubMed ID: 21232767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to the Newborn Screening, Diagnosis, and Treatment for Pompe Disease Guidance Supplement.
    Kishnani PS; Hwu WL;
    Pediatrics; 2017 Jul; 140(Suppl 1):S1-S3. PubMed ID: 29162672
    [No Abstract]   [Full Text] [Related]  

  • 5. Pompe disease in infants: improving the prognosis by newborn screening and early treatment.
    Chien YH; Lee NC; Thurberg BL; Chiang SC; Zhang XK; Keutzer J; Huang AC; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2009 Dec; 124(6):e1116-25. PubMed ID: 19948615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat?
    Laloui K; Wary C; Carlier RY; Hogrel JY; Caillaud C; Laforêt P
    Neurology; 2011 Aug; 77(6):594-5. PubMed ID: 21753173
    [No Abstract]   [Full Text] [Related]  

  • 7. Severely impaired health status at diagnosis of Pompe disease: a cross-sectional analysis to explore the potential utility of neonatal screening.
    Rigter T; Weinreich SS; van El CG; de Vries JM; van Gelder CM; Güngör D; Reuser AJ; Hagemans ML; Cornel MC; van der Ploeg AT
    Mol Genet Metab; 2012 Nov; 107(3):448-55. PubMed ID: 23040796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I'm fine; I'm just waiting for my disease": the new and growing class of presymptomatic patients.
    Kwon JM; Steiner RD
    Neurology; 2011 Aug; 77(6):522-3. PubMed ID: 21753177
    [No Abstract]   [Full Text] [Related]  

  • 9. Late onset Pompe disease revealed by newborn screening.
    Levenson D
    Am J Med Genet A; 2011 May; 155A(5):fmviii-ix. PubMed ID: 21506259
    [No Abstract]   [Full Text] [Related]  

  • 10. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
    Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations.
    Kemper AR; Hwu WL; Lloyd-Puryear M; Kishnani PS
    Pediatrics; 2007 Nov; 120(5):e1327-34. PubMed ID: 17974725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum.
    Kronn DF; Day-Salvatore D; Hwu WL; Jones SA; Nakamura K; Okuyama T; Swoboda KJ; Kishnani PS;
    Pediatrics; 2017 Jul; 140(Suppl 1):S24-S45. PubMed ID: 29162675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for late-onset Pompe disease with enzyme replacement therapy: The two sides of low BMI.
    Ravaglia S; Carlucci A; Danesino C
    Mol Genet Metab; 2010 Aug; 100(4):388. PubMed ID: 20472481
    [No Abstract]   [Full Text] [Related]  

  • 14. Health and economic outcomes of newborn screening for infantile-onset Pompe disease.
    Richardson JS; Kemper AR; Grosse SD; Lam WKK; Rose AM; Ahmad A; Gebremariam A; Prosser LA
    Genet Med; 2021 Apr; 23(4):758-766. PubMed ID: 33281187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pompe disease: literature review and case series.
    Dasouki M; Jawdat O; Almadhoun O; Pasnoor M; McVey AL; Abuzinadah A; Herbelin L; Barohn RJ; Dimachkie MM
    Neurol Clin; 2014 Aug; 32(3):751-76, ix. PubMed ID: 25037089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
    Young SP; Piraud M; Goldstein JL; Zhang H; Rehder C; Laforet P; Kishnani PS; Millington DS; Bashir MR; Bali DS
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):50-8. PubMed ID: 22252961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of nutritional status in the prognosis of late onset Pompe disease.
    Papadimas GK; Terzis G; Papadopoulos C; Spengos K; Manta P
    Mol Genet Metab; 2010 Aug; 100(4):389. PubMed ID: 20488740
    [No Abstract]   [Full Text] [Related]  

  • 18. The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease.
    Laforêt P; Laloui K; Granger B; Hamroun D; Taouagh N; Hogrel JY; Orlikowski D; Bouhour F; Lacour A; Salort-Campana E; Penisson-Besnier I; Sacconi S; Zagnoli F; Chapon F; Eymard B; Desnuelle C; Pouget J;
    Rev Neurol (Paris); 2013; 169(8-9):595-602. PubMed ID: 24008051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective diagnosis of glycogen storage disease type II by use of a newborn-screening card.
    Niizawa G; Levin C; Aranda C; Blanco M; Chamoles NA
    Clin Chim Acta; 2005 Sep; 359(1-2):205-6. PubMed ID: 15963968
    [No Abstract]   [Full Text] [Related]  

  • 20. [POMPE DISEASE - GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF ADULT PATIENTS].
    Pećin I; Muačević-Katanec D; Šimić I; Fumić K; Potočki K; Šućur N; Reiner Ž;
    Lijec Vjesn; 2015; 137(7-8):216-8. PubMed ID: 26502670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.